CIM
EW icon

Chiron Investment Management’s Edwards Lifesciences EW Stock Holding History

Chiron Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600,927
Closed -$34.9M – 55
2018
Q3 		$34.9M Sell
600,927
-137,901
-19% -$6.74M 2.22% 26
2018
Q2 		$35.9M Buy
738,828
+176,034
+31% +$8.22M 2.47% 23
2018
Q1 		$26.2M Buy
+562,794
New +$24.4M 2.28% 27

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Chiron Investment Management's EW Position: Q4 2018 in Review

Chiron Investment Management sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 600,927 shares — an estimated $34.9M sold.

Chiron Investment Management first reported a position in EW in Q1 2018 and held it in 3 quarters. The position peaked at $35.9M in Q2 2018. 874 funds tracked by Wall St. Rank hold EW as of Q4 2018.

  • Chiron Investment Management reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
  • Chiron Investment Management sold 600,927 Edwards Lifesciences shares in Q4 2018, an estimated $34.9M.
  • Chiron Investment Management first reported a position in Edwards Lifesciences in Q1 2018 and held it in 3 quarters.
  • Chiron Investment Management's Edwards Lifesciences position peaked at $35.9M in Q2 2018.
  • 874 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Chiron Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.